Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 11 min ago
Peer-reviewedCC BY 4.0The Lancet Global Health

Immunogenicity and safety of Sabin inactivated poliovirus vaccine in a sequential schedule with bivalent oral poliovirus vaccine in Nepal: a single-centre, double-blind, randomised, controlled, non-inferiority trial

Related

  1. Child, Parental, and Household Factors on Inactivated Poliovirus Vaccine Use
    Tutut Okta Hardiyanti, Ayun Sriatmi, Martini +4
    KEMAS: Jurnal Kesehatan MasyarakatPeer-reviewedCC BYFull textEpidemiology & public healthDOAJ
  2. Immunogenicity and safety of an interchangeable vaccination schedule of two inactivated Japanese encephalitis vaccines: a multicentric, phase IV, open-label, randomized controlled trial
    Jeromie Wesley Vivian Thangaraj, Himabindu Reddy, Gajanan N. Sapkal +33
    EClinicalMedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  3. Comparative immunogenicity of several inactivated influenza vaccines among healthcare workers in Hong Kong
    W. W. Lim, L. Touyon, L. Mak +6
    medRxivPreprintCC BYFull textInfectious diseasemedRxiv
  4. Immunogenicity and Protective Efficacy of a Trivalent Whole-Virion Inactivated SARS-CoV-2 Vaccine Against Vaccine-Matched Ancestral, Delta, and Omicron BA.5 Variants in K18-hACE2 Mice.
    Hazel Yetiskin, Muhammet Ali Uygut, Shaikh Terkis Islam Pavel +2
    VirusesPeer-reviewedCC BYFull textInfectious diseaseEurope PMC
  5. Randomized non-inferiority within-patient trial of density gradient processing of sequential ejaculates versus centrifugation-free sperm separation device for ICSI in men with elevated sperm DNA fragmentation- study protocol
    Vipin Chandra, Shashank Sanagoudar, Jayesh Shinde +3
    Frontiers in urologyPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{sharma2026immunogenicity,
  title = {{Immunogenicity and safety of Sabin inactivated poliovirus vaccine in a sequential schedule with bivalent oral poliovirus vaccine in Nepal: a single-centre, double-blind, randomised, controlled, non-inferiority trial}},
  author = {Arun K Sharma and Visalakshi Jeyaseelan and Sudha Basnet and Shreejana Dangol and Dhruba Shrestha and Ganendra B Raya and Bernardo A Mainou and Kathryn A V Jones and Laxman P Shrestha and Ondrej Mach and Harish Verma},
  journal = {The Lancet Global Health},
  year = {2026},
  month = nov,
  doi = {10.1016/j.langlo.2026.104083},
  url = {https://linkinghub.elsevier.com/retrieve/pii/S2214109X26002457},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Immunogenicity and safety of Sabin inactivated poliovirus vaccine in a sequential schedule with bivalent oral poliovirus vaccine in Nepal: a single-centre, double-blind, randomised, controlled, non-inferiority trial
AU  - Arun K Sharma
AU  - Visalakshi Jeyaseelan
AU  - Sudha Basnet
AU  - Shreejana Dangol
AU  - Dhruba Shrestha
AU  - Ganendra B Raya
AU  - Bernardo A Mainou
AU  - Kathryn A V Jones
AU  - Laxman P Shrestha
AU  - Ondrej Mach
AU  - Harish Verma
PY  - 2026
DA  - 2026/11/01
JO  - The Lancet Global Health
DO  - 10.1016/j.langlo.2026.104083
UR  - https://linkinghub.elsevier.com/retrieve/pii/S2214109X26002457
SN  - 2214-109X
ER  -